IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose...

por Ji, Linong, Jiang, Hongwei, An, Pei, Deng, Huan, Liu, Meng, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei
Publicado 2021

Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled,...

por Ji, Linong, Gao, Leili, Jiang, Hongwei, Yang, Jing, Yu, Lei, Wen, Jie, Cai, Chenghang, Deng, Huan, Feng, Liqi, Song, Baili, Ma, Qingyang, Qian, Lei
Publicado 2022

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes

por Jiang, Hongwei, Pang, Shuguang, Zhang, Yawei, Yu, Ting, Liu, Meng, Deng, Huan, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei, Yang, Wenying
Publicado 2022

A NADE nomogram to predict the probability of 6-month unfavorable outcome in Chinese patients with ischemic stroke

por Sun, Chao, Li, Xiang, Song, Baili, Chen, Xiangliang, Nyame, Linda, Liu, Yukai, Tang, Dan, Ibrahim, Mako, Zhao, Zheng, Liu, Chao, Yan, Miao, Pan, Xiding, Yang, Jie, Zhou, Junshan, Zou, Jianjun
Publicado 2019

Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke Etiology

por Sun, Chao, Li, Xiang, Zhao, Zheng, Chen, Xiangliang, Huang, Chaoping, Li, Xuemei, Shan, Yajie, Zou, Yang, Liu, Yukai, Ibrahim, Mako, Nyame, Linda, Song, Baili, Wang, Fusang, Zheng, Xiaohan, Hu, Jue, Zhao, Zhihong, Zhou, Junshan, Zou, Jianjun
Publicado 2019